Lisata Therapeutics Statistics
Total Valuation
LSTA has a market cap or net worth of $9.65 million. The enterprise value is -$790,226.
| Market Cap | 9.65M |
| Enterprise Value | -790,226 |
Important Dates
The next estimated earnings date is Friday, November 6, 2026, after market close.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LSTA has 9.11 million shares outstanding. The number of shares has increased by 5.10% in one year.
| Current Share Class | 9.11M |
| Shares Outstanding | 9.11M |
| Shares Change (YoY) | +5.10% |
| Shares Change (QoQ) | +1.11% |
| Owned by Insiders (%) | 20.89% |
| Owned by Institutions (%) | 11.59% |
| Float | 7.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 96.53 |
| Forward PS | n/a |
| PB Ratio | 1.17 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.69
| Current Ratio | 3.69 |
| Quick Ratio | 3.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -101.66% and return on invested capital (ROIC) is -71.26%.
| Return on Equity (ROE) | -101.66% |
| Return on Assets (ROA) | -56.74% |
| Return on Invested Capital (ROIC) | -71.26% |
| Return on Capital Employed (ROCE) | -204.32% |
| Weighted Average Cost of Capital (WACC) | 9.08% |
| Revenue Per Employee | $4,762 |
| Profits Per Employee | -$696,238 |
| Employee Count | 21 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -387,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.19% in the last 52 weeks. The beta is 0.88, so LSTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -64.19% |
| 50-Day Moving Average | 2.87 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 19.29 |
| Average Volume (20 Days) | 132,014 |
Short Selling Information
The latest short interest is 129,920, so 1.43% of the outstanding shares have been sold short.
| Short Interest | 129,920 |
| Short Previous Month | 104,813 |
| Short % of Shares Out | 1.43% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 3.77 |
Income Statement
In the last 12 months, LSTA had revenue of $100,000 and -$14.62 million in losses. Loss per share was -$1.64.
| Revenue | 100,000 |
| Gross Profit | 100,000 |
| Operating Income | -16.43M |
| Pretax Income | -15.01M |
| Net Income | -14.62M |
| EBITDA | -16.36M |
| EBIT | -16.43M |
| Loss Per Share | -$1.64 |
Balance Sheet
The company has $10.44 million in cash and no debt, with a net cash position of $10.44 million or $1.15 per share.
| Cash & Cash Equivalents | 10.44M |
| Total Debt | n/a |
| Net Cash | 10.44M |
| Net Cash Per Share | $1.15 |
| Equity (Book Value) | 7.99M |
| Book Value Per Share | 0.90 |
| Working Capital | 8.03M |
Cash Flow
| Operating Cash Flow | -12.32M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 64,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.32M |
| FCF Per Share | -$1.35 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -16,426.00% |
| Pretax Margin | -15,008.00% |
| Profit Margin | n/a |
| EBITDA Margin | -16,363.00% |
| EBIT Margin | -16,427.00% |
| FCF Margin | n/a |
Dividends & Yields
LSTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -151.47% |
| FCF Yield | -127.66% |
Analyst Forecast
The average price target for LSTA is $4.00, which is 277.36% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.00 |
| Price Target Difference | 277.36% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 248.57% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 15, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |